(Q47771140)

5 February 2018

title

Recombinant TFPI and variants: potential implications in the treatment of cardiovascular disorders (English)

1 reference

5 February 2018

author name string

Kaiser B

series ordinal

1

1 reference

5 February 2018

Hoppensteadt DH

series ordinal

2

1 reference

5 February 2018

Fareed J

series ordinal

3

1 reference

5 February 2018

language of work or name

English

0 references

publication date

1 July 1998

1 reference

5 February 2018

Expert Opinion on Investigational Drugs

published in

1 reference

5 February 2018

volume

7

1 reference

5 February 2018

issue

7

1 reference

5 February 2018

page(s)

1121-1137

1 reference

5 February 2018

Structural biology, cellular interactions and pathophysiology of the contact system

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.7.1121

Tissue factor pathway inhibitor and the revised theory of coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.7.1121

Cell biology of tissue factor, the principal initiator of blood coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.7.1121

The protein C anticoagulant system: inherited defects as basis for venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.7.1121

Regulation of coagulation by a multivalent Kunitz-type inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.7.1121

Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.7.1121

Endogenous phosphorylation of the lipoprotein-associated coagulation inhibitor at serine-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.7.1121

Kinetics of the inhibition of human factor Xa by full-length and truncated recombinant tissue factor pathway inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.7.1121

Inhibitory properties of separate recombinant Kunitz-type-protease-inhibitor domains from tissue-factor-pathway inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.7.1121

Regulation of the extrinsic pathway system in health and disease: the role of factor VIIa and tissue factor pathway inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.7.1121

Venous thrombosis produced in the vena cava of rabbits by vascular damage and stasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.7.1121

Heparin induces release of extrinsic: Coagulation pathway inhibitor (EPI)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.7.1121

Low levels of tissue factor pathway inhibitor (TFPI) in two out of three members of a family with thrombophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.7.1121

Selective Inhibition of Factor Xa Is More Efficient Than Factor VIIa–Tissue Factor Complex Blockade at Facilitating Coronary Thrombolysis in the Canine Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.7.1121

10.1517/13543784.7.7.1121

21 January 2018

Identifiers

DOI

1 reference

5 February 2018

1 reference

5 February 2018